Showing results (1-10 of 72) with videos related to
Sort By:
Pageof 8
Gastroenterology|February 22, 2011
Nuclear receptors as new perspective for the management of liver diseasesMichael Trauner, Emina HalilbasicClinics in Liver Disease|April 2, 2013
Nuclear receptors as drug targets in cholestatic liver diseasesEmina Halilbasic, Anna Baghdasaryan, Michael TraunerDigestive Diseases (Basel, Switzerland)|March 2, 2017
Nor-Ursodeoxycholic Acid as a Novel Therapeutic Approach for Cholestatic and Metabolic Liver DiseasesEmina Halilbasic, Daniel Steinacher, Michael TraunerJournal of Hepatology|August 14, 2012
Bile acid transporters and regulatory nuclear receptors in the liver and beyondEmina Halilbasic, Thierry Claudel, Michael TraunerDigestive Diseases (Basel, Switzerland)|June 23, 2016
Farnesoid X Receptor Agonists and Other Bile Acid Signaling Strategies for Treatment of Liver DiseaseEmina Halilbasic, Claudia Fuchs, Stefan Traussnigg, et al.Current Opinion in Gastroenterology|March 15, 2014
Fibrate treatment for primary biliary cirrhosisFrans J C Cuperus, Emina Halilbasic, Michael TraunerWiener Medizinische Wochenschrift (1946)|November 11, 2008
Lessons from the toxic bile concept for the pathogenesis and treatment of cholestatic liver diseasesMichael Trauner, Peter Fickert, Emina Halilbasic, et al.Innere Medizin (Heidelberg, Germany)|March 18, 2024
[Primary sclerosing cholangitis-Diagnosis and treatment 2024]Michael Trauner, Emina Halilbasic, Elisabeth Tatscher, et al.Best Practice & Research. Clinical Gastroenterology|November 29, 2011
Pathogenesis of primary sclerosing cholangitisMarion J Pollheimer, Emina Halilbasic, Peter Fickert, et al.Hepatology (Baltimore, Md.)|December 21, 2016
New therapeutic concepts in bile acid transport and signaling for management of cholestasisMichael Trauner, Claudia Daniela Fuchs, Emina Halilbasic, et al.Pageof 8